Cargando…
NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is characterized by a progressive increase in pulmonary vascular resistance and obliterative pulmonary vascular remodelling (PVR). The imbalance between the proliferation and apoptosis of pulmonary artery smooth muscle cells (PASMCs) is an important cause of PVR...
Autores principales: | Liu, Yun, Nie, Xiaowei, Zhu, Jinquan, Wang, Tianyan, Li, Yanli, Wang, Qian, Sun, Zengxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812284/ https://www.ncbi.nlm.nih.gov/pubmed/33340241 http://dx.doi.org/10.1111/jcmm.16193 |
Ejemplares similares
-
Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2
por: Sun, Zengxian, et al.
Publicado: (2022) -
Thromboxane promotes smooth muscle phenotype commitment but not remodeling of hypoxic neonatal pulmonary artery
por: Postolow, Fabiana, et al.
Publicado: (2015) -
Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension
por: Hinton, Martha, et al.
Publicado: (2023) -
The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension
por: Wang, Yanxia, et al.
Publicado: (2021) -
Granzyme B deficiency promotes osteoblastic differentiation and calcification of vascular smooth muscle cells in hypoxic pulmonary hypertension
por: Mao, Min, et al.
Publicado: (2018)